Alpha Pharma sells its tamoxifen under the Altamofen name, and this is the 10 mg tablet in a fifty-count pack.
The compound is a SERM, a selective estrogen receptor modulator, first developed in oncology and still used there against estrogen-sensitive tumours. Its behaviour is tissue-dependent: antagonist at the breast receptor, partial agonist elsewhere in the body. That mixed profile is what separates it from drugs which simply shut estrogen production down.
Alpha Pharma prints a scratch-off authentication code on its cartons, a habit the company has kept across its whole oral range for years.
